The importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasia

Basit Öğe Kaydı
dc.contributor.authorAksit, Ercan
dc.contributor.authorKucuk, Ugur
dc.contributor.authorTaylan, Gokay
dc.contributor.authorCinier, Goksel
dc.contributor.authorKarabay, Can Yucel
dc.contributor.authorAkgun, Taylan
dc.date.accessioned2025-01-27T21:13:05Z
dc.date.available2025-01-27T21:13:05Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[Anstract Not Available]
dc.identifier.doi10.1016/j.ijcard.2022.01.025
dc.identifier.endpage53
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.pmid35051491
dc.identifier.scopus2-s2.0-85126301466
dc.identifier.scopusqualityQ1
dc.identifier.startpage53
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2022.01.025
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28277
dc.identifier.volume353
dc.identifier.wosWOS:000784330500012
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofInternational Journal of Cardiology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectAnti-fibrotic drugs
dc.subjectArrhythmogenic cardiomyopathy
dc.subjectCardiac fibrosis
dc.subjectRemodeling
dc.titleThe importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasia
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu